France
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 12.19 B
|
Dec. 31, 2023 | USD 107.78 | 1.15% |
|
France |
|
2 |
USD 98.59 M
|
Dec. 31, 2023 | USD 75.53 | 2.94% |
|
France |
|
3 |
USD 51.31 M
|
Dec. 31, 2023 | USD 2.01 | -0.78% |
|
France |
|
4 |
USD 45.97 M
|
Dec. 31, 2023 | USD 3.21 | 17.34% |
|
France |
|
5 |
USD 29.73 M
|
Dec. 31, 2023 | USD 26.53 | -0.92% |
|
France |
|
6 |
USD 21.08 M
|
Dec. 31, 2023 | USD 5.91 | -2.66% |
|
France |
|
7 |
USD 17.34 M
|
Dec. 31, 2023 | USD 2.43 | 0.68% |
|
France |
|
8 |
USD 15.45 M
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
9 |
USD 10.48 M
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
10 |
USD 5.67 M
|
Dec. 31, 2023 | USD 3.53 | -0.92% |
|
France |
|
11 |
USD 2.43 M
|
March 31, 2024 | USD 16.83 | 1.50% |
|
France |
|
12 |
USD 1.94 M
|
Dec. 31, 2023 | USD 2.58 | -11.21% |
|
France |
|
13 |
USD 260.49 K
|
Dec. 31, 2023 | USD 1.64 | 4.90% |
|
France |
|
14 |
USD 136.82 K
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
15 |
USD 124.72 K
|
Dec. 31, 2023 | USD 1.39 | 1.77% |
|
France |
|
16 |
USD 122.52 K
|
Dec. 31, 2023 | USD 5.64 | -2.27% |
|
France |
|
17 |
USD 0.00
|
Dec. 31, 2023 | USD 6.63 | -0.22% |
|
France |
The Vaccines company in France with the highest Receivables is Sanofi (Paris Stock Exchange: SAN.PA) at USD 12.19 B.
The Vaccines company in France with the lowest Receivables is OSE Immunotherapeutics SA (Paris Stock Exchange: OSE.PA) at USD 0.00.
The top 10 Vaccines companies in France by Receivables are Sanofi, Vetoquinol SA, Innate Pharma S.A., Valneva SE, Eurobio Scientific SA, ABIVAX SA, Inventiva S.A., DBV Technologies S.A., Nanobiotix S.A. and genOway SA.
The bottom 10 Vaccines companies in France by Receivables are OSE Immunotherapeutics SA, Adocia SA, Valbiotis SA, Novacyt S.A., AB Science S.A., Aelis Farma SA, MedinCell S.A., genOway SA, Nanobiotix S.A. and DBV Technologies S.A..